GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.

More than 35 million people in the U.S. have chronic kidney disease (CKD), a condition in which the kidneys are damaged and ...

Chronic kidney disease (CKD) is a progressive renal disease that causes kidney function to deteriorate. It appears as urinary ...

Once kidney function is lost, it cannot be restored. If CKD progresses, the only options are dialysis or transplantation. We ...

张医生仔细做了检查，发现患有多年慢性肾脏病（CKD）的李大妈病情出现了反复，尿白蛋白/尿肌酐（UACR）也由春节前的 150 mg/g 升至 262.3 ...

Patients with chronic kidney disease and those who have had a kidney transplant should avoid high doses of vitamin D, according to an evidence-based consensus document. “Vitamin D deficiency is common ...

Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...